|

Ribociclib Succinate Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Kisqali

Pipeline

Phase 3: 1

Top Sponsors

  • National Cancer Institute (NCI)1

Indications

  • Anatomic Stage IIIC Breast Cancer AJCC v81
  • Anatomic Stage IIIA Breast Cancer AJCC v81
  • Estrogen Receptor-Positive Breast Carcinoma1
  • HER2-Negative Breast Carcinoma1
  • Anatomic Stage II Breast Cancer AJCC v81

Jonesboro, Arkansas1 trial

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.